| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/25/2014 | CN102731493B 一类抗肿瘤含苯并噻唑杂环结构的化合物及其应用 One class of anti-tumor and thiazole compounds of benzene and its application heterocyclic structure |
| 06/25/2014 | CN102731285B 一类蒽醌类化合物及其应用 A class of anthraquinone compounds and its application |
| 06/25/2014 | CN102718881B 一种灵芝多糖的高效纯化技术 Ganoderma lucidum polysaccharides efficient purification techniques |
| 06/25/2014 | CN102712591B 3-羟基吡啶-4-酮的氟化衍生物 Fluorinated derivatives of 3-hydroxy-pyridin-4-one |
| 06/25/2014 | CN102688300B 药物组合物及其用途 The pharmaceutical compositions and uses thereof |
| 06/25/2014 | CN102675325B 含哌嗪乙氧基修饰基团的酞菁金属配合物及其制备方法 Group metal phthalocyanine complexes containing piperazine and its preparation method modified ethoxylate |
| 06/25/2014 | CN102652773B 药物组合物及其制备方法 The pharmaceutical composition and its preparation method |
| 06/25/2014 | CN102643252B 含哌嗪乙酰肼的双芳基脲类衍生物及其应用 Acetohydrazide containing piperazine bis-aryl urea derivatives and its application |
| 06/25/2014 | CN102633883B 一种能与egfr、her2、vegf高效结合的融合蛋白、其编码序列及用途 One kind with egfr, her2, vegf efficient binding of the fusion protein, the coding sequence and use |
| 06/25/2014 | CN102631347B 一种吉非替尼药物组合物及其制备方法 One kind of gefitinib pharmaceutical composition and its preparation method |
| 06/25/2014 | CN102627614B 二喹唑啉二硒醚类化合物及制备方法和生物活性 Two quinazoline diselenide ether compound and preparation method and biological activity |
| 06/25/2014 | CN102627610B 一类苯并咪唑类衍生物及其应用 A class of benzimidazole derivatives and their application |
| 06/25/2014 | CN102618452B 唾液乳杆菌及其代谢物的制备方法和组合物以及应用 Lactobacillus salivarius and its metabolites methods and compositions for the preparation and application |
| 06/25/2014 | CN102574852B Akt抑制剂 Akt inhibitors |
| 06/25/2014 | CN102516258B 水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用 Derivative modified with water-soluble vitamins e liposoluble anticancer drug compounds and formulations of the compounds and the preparation of applications |
| 06/25/2014 | CN102482258B α-螺旋模拟物和与其相关的方法 α- helix mimetics, and methods related thereto |
| 06/25/2014 | CN102481253B 包含羟基氯喹的用于抗癌治疗的局部投药用注射剂组合物 Hydroxychloroquine comprising topical administration for the treatment of anti-cancer pharmaceutical composition for injection |
| 06/25/2014 | CN102432485B 一种α,β-二氨基酸衍生物及其合成方法和应用 One kind of α, β- two amino acid derivatives and a synthesis method and application |
| 06/25/2014 | CN102429869B 包裹度可控的负载药物的硬脂酸载药微纳米粒的制备方法 Preparation stearate degree controlled drug package drug-loaded nanoparticles micro |
| 06/25/2014 | CN102151282B 环烯醚萜苷及其衍生物作为纤溶酶抑制剂的应用及其药物组合物 Iridoid glycosides and their derivatives as an application plasmin inhibitor and pharmaceutical compositions thereof |
| 06/25/2014 | CN102146108B 具有抗癌活性的3′-叠氮基表阿霉素的合成 With anticancer activity 3'-azido epirubicin synthesis |
| 06/25/2014 | CN102026667B 紫杉醇、紫杉醇类似物或紫杉醇结合物的药物组合物及相关制备方法和用途 Pharmaceutical compositions and methods related to the preparation and use of paclitaxel, paclitaxel analogues, or paclitaxel conjugate |
| 06/25/2014 | CN101948475B 异黄酮衍生物-色烯(满)并噁嗪类化合物及其制备方法和应用 Isoflavone Derivatives - chromene (full) and oxazine compound and preparation method and application |
| 06/25/2014 | CN101830828B 一种Salen Zn(II)配合物及其制备方法和应用 One kind of Salen Zn (II) complex and its preparation method and application |
| 06/25/2014 | CN101765370B 硫辛酸衍生物 Lipoic acid derivatives |
| 06/25/2014 | CN101759645B p38抑制剂及它们的使用方法 p38 inhibitors and methods for their use |
| 06/25/2014 | CN101623286B 包含葫芦素类活性成分的经皮给药组合物 Transdermal drug delivery compositions comprising the active ingredient Cucurbitacin class |
| 06/25/2014 | CN101591226B 1,3-二芳基丙烷类衍生物及其用途 Propane-1,3-aryl derivatives and their use |
| 06/25/2014 | CN101503402B 2-苯胺嘧啶衍生物及其制备和用途 2-anilino-pyrimidine derivatives and their preparation and use |
| 06/25/2014 | CN101434592B 朝鲜槐中提取的黄酮类化合物 North Huai flavonoids extracted |
| 06/24/2014 | US8759613 Method of producing a lunasin polypeptide in plants |
| 06/24/2014 | US8759493 MN gene and protein |
| 06/24/2014 | US8759370 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 06/24/2014 | US8759359 Substituted heteroaryl fused derivatives as PI3K inhibitors |
| 06/24/2014 | US8759327 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism |
| 06/24/2014 | US8759097 Inhibition of dynamin related protein 1 to promote cell death |
| 06/24/2014 | US8759006 PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia |
| 06/24/2014 | US8758753 Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors |
| 06/24/2014 | US8758743 Compositions containing coenzyme Q10 |
| 06/19/2014 | WO2014093960A1 Compositions and methods for treating disease |
| 06/19/2014 | WO2014093950A1 Immune modulator for immunotherapy and vaccine formulation |
| 06/19/2014 | WO2014093723A2 Group-assistant-purification (gap) synthesis of velcade, dimeric analogs, and amino compounds |
| 06/19/2014 | WO2014093383A1 Substituted 1h-pyrrolo [2,3-b] pyridine and 1h-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (sik2) inhibitors |
| 06/19/2014 | WO2014093313A1 Compositions and methods for integrated metabolic interventions |
| 06/19/2014 | WO2014093270A1 Tropism modified cancer terminator virus (ad.5/3 ctv;ad.5/3-ctv-m7) |
| 06/19/2014 | WO2014093240A1 Bivalent il-2 fusion toxins |
| 06/19/2014 | WO2014093230A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity |
| 06/19/2014 | WO2014092905A1 Methods and assays for combination treatment of cancer |
| 06/19/2014 | WO2014092572A1 Improved methods for cancer treatment with a genotoxic agent |
| 06/19/2014 | WO2014092532A1 Anti-proliferative effects of palm vegetation liquor and extracts thereof in preventing pancreatic cancer |
| 06/19/2014 | WO2014092489A1 Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredient |
| 06/19/2014 | WO2014092175A1 Specific polyphenol used in food and drink products, supplements, pharmaceuticals, and the like and method for manufacturing said specific polyphenol |
| 06/19/2014 | WO2014091446A1 Pyrimido [4,5-b]quinoline-4,5 (3h,10h)-diones as nonsense mutation suppressors |
| 06/19/2014 | WO2014091265A1 Pyrimidine-2,4-diamine derivatives as kinase inhibitors |
| 06/19/2014 | WO2014091241A1 Chlorin derivative useful in photodynamic therapy and diagnosis |
| 06/19/2014 | WO2014091078A1 Polymeric particles-based temozolomide dosage form |
| 06/19/2014 | WO2014090948A1 Serpin spn4a and biologically active derivatives thereof for use in the treatment of cancer |
| 06/19/2014 | WO2014090709A1 Dimeric compounds |
| 06/19/2014 | WO2014090586A1 Delphinidin for combating melanoma cells |
| 06/19/2014 | WO2014090583A1 Delphinidin for combating melanoma cells |
| 06/19/2014 | WO2014090396A2 Use of maleimide derivatives for preventing and treating cancer |
| 06/19/2014 | WO2014090259A1 Product comprising red clover extract and methods for producing the same |
| 06/19/2014 | WO2014090224A1 Use of active substance combinations for inducing tumour senescence |
| 06/19/2014 | WO2014090185A1 Application of silicon dioxide aerogel in pharmacy |
| 06/19/2014 | WO2014090176A1 Nanoscale platinum drug and preparation method thereof |
| 06/19/2014 | WO2014090174A1 Nanoscale capecitabine and preparation method therefor |
| 06/19/2014 | WO2014090173A1 Nanoscale doxorubicin hydrochloride and preparation method therefor |
| 06/19/2014 | WO2014090171A1 Nanoscale cyclophosphamide and preparation method thereof |
| 06/19/2014 | WO2014090169A1 Nanoscale paclitaxel and preparation method thereof |
| 06/19/2014 | WO2014090168A1 Nanoscale docetaxel and preparation method thereof |
| 06/19/2014 | WO2014090147A1 Pyrimidine derivatives and salts thereof, preparation method and pharmaceutical use thereof |
| 06/19/2014 | WO2014090128A1 Arteannuin cyclodextrin conjugate and preparing method thereof |
| 06/19/2014 | WO2014090127A1 Cyclodextrin carrier-based arteannuin compound conjugate and preparing method thereof |
| 06/19/2014 | WO2014090053A1 Monoclonal antibody for antagonizing and inhibiting binding of vascular endothelial cell growth factor and its receptor, and coding sequence and use thereof |
| 06/19/2014 | WO2014089957A1 Stable busulfan injection |
| 06/19/2014 | WO2014089913A1 Bicyclic compound functioning as tyrosine kinase inhibitor |
| 06/19/2014 | WO2014089668A1 Compositions and methods for the treatment of brain cancers |
| 06/19/2014 | WO2014063054A8 Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof |
| 06/19/2014 | WO2014062720A3 Methods of treating cancer |
| 06/19/2014 | WO2013126146A3 Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate |
| 06/19/2014 | US20140171439 Inhibitors Of Histone Deacetylase |
| 06/19/2014 | US20140171366 Compounds and methods for treating cancer |
| 06/18/2014 | EP2743271A1 Pim kinase inhibitor and preparation method and use in medicinal manufacture thereof |
| 06/18/2014 | EP2743269A1 Pim kinase inhibitor, preparation method and use thereof in drug preparation |
| 06/18/2014 | EP2743266A2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon |
| 06/18/2014 | EP2743264A1 New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof |
| 06/18/2014 | EP2743252A1 Tetravalent platinum complex and pharmaceutical composition containing same |
| 06/18/2014 | EP2742956A1 Medicinal agent for medical applications, and method for searching for novel medicinal agent |
| 06/18/2014 | EP2742950A1 Pharmaceutical composition containing fibulin-3 protein as an active ingredient for inhibiting the growth of cancer stem cells |
| 06/18/2014 | EP2742361A1 Angiopoietin-like 4 and its use in modulating cell leakiness |
| 06/18/2014 | EP2742133A1 Mphosph1 peptides and vaccines including the same |
| 06/18/2014 | EP2742067A2 Anti-fzd10 monoclonal antibodies and methods for their use |
| 06/18/2014 | EP2742046A1 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 06/18/2014 | EP2742043A1 Pyrido-pyrimidine derivatives |
| 06/18/2014 | EP2742029A1 N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists |
| 06/18/2014 | EP2742020A2 N1-cyclic amine-n5-substituted biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 06/18/2014 | EP2742019A2 N1-cyclic amine-n5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same |
| 06/18/2014 | EP2741775A1 Polymeric nanoparticles for photosensitizers |
| 06/18/2014 | EP2741774A2 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
| 06/18/2014 | EP2741748A1 Beta-lactam compounds for enhancing t cell-mediated immune responses |